Impact of Vitamin D Binding Protein Levels on Alzheimer's Disease: A Mendelian Randomization Study.

doi:10.3233/JAD-191051

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Impact of Vitamin D Binding Protein Levels on Alzheimer's Disease: A Mendelian Randomization Study.

Journal of Alzheimer's disease : JAD - 1 Jan 2020

Zhang Haihua, Wang Tao, Han Zhifa, Wang Longcai, Zhang Yan, Wang Lijun, Liu Guiyou

Abstract excerpt

Until now, observational studies, randomized controlled trials (RCTs), and Mendelian randomization (MR) studies have explored the impact of vitamin D on Alzheimer's disease (AD), and reported inconsistent findings. In MR studies, the sensitivity analysis by removing GC rs2282679 variant highlighted no association of 25OHD levels with AD risk, which indicates that vitamin D-binding protein (DBP) encoded by GC may...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Causality

Share to Genetic Variation

Share to Genome-Wide Association Study

Share to Genotype

Share to Mendelian Randomization Analysis

Share to Risk Assessment

Share to Vitamin D-Binding Protein

Source

Open in PubMed

Identifiers

PMID: 32116251
DOI: 10.3233/JAD-191051

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of Vitamin D Binding Protein Levels on Alzheimer's Disease: A Mendelian Randomization Study.PMID 32116251Read ↗

Circulating Vitamin D Levels and Alzheimer’s Disease: A Mendelian Randomization Study in the IGAP and UK BiobankSemantic proximity Read ↗

Systematic evaluation of multifactorial causal associations for Alzheimer's disease and an interactive platform based on Mendelian randomization analysis——MRADSemantic proximity Read ↗

Relationship between diastolic blood pressure and Alzheimer disease: A 2-sample Mendelian randomization study based on an automated screening method for exposure factors and empirical validation.Semantic proximity Read ↗

Systematic evaluation of multifactorial causal associations for Alzheimer's disease and an interactive platform MRAD developed based on Mendelian randomization analysis.Semantic proximity Read ↗

Genetically decreased vitamin D and risk of Alzheimer disease.Semantic proximity Read ↗

AlzRiskMR database: an online database for the impact of exposure factors on Alzheimer's disease.Semantic proximity Read ↗

Associations between Potentially Modifiable Risk Factors and Alzheimer Disease: A Mendelian Randomization Study.Semantic proximity Read ↗

High Blood Pressure and Risk of Dementia: A Two-Sample Mendelian Randomization Study in the UK BiobankSemantic proximity Read ↗

Angiotensin-converting enzyme inhibition and Alzheimer’s disease: Findings from proteome-wide Mendelian randomization and a large prospective cohort studySemantic proximity Read ↗

The causal effect of vitamin D binding protein (DBP) levels on calcemic and cardiometabolic diseases: a Mendelian randomization study.Semantic proximity Read ↗

Causal Effects Between Blood Pressure Variability and Alzheimer's Disease: A Two-Sample Mendelian Randomization Study.Semantic proximity Read ↗

Causal Relationship between Inflammatory Proteins and Alzheimer's Disease: A Two-Sample Bidirectional Mendelian Randomization Study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.